Mast Therapeutics, Inc. (MSTX)

[buy4long]

I would like to think there is enough interest that someone is angling to accumulate shares at a low pps. However, I think the real truth is that MSTX is just off the radar. Even with good EPIC and AIR001 data, we will need more money, either from ATM or partnership (preferred). Until all data is in, and financial situation is better than next 'few quarters', we'll be a sub $2 stock. Of course, that could still be a 3x-4x from where we are now. IMHO, however, in 5 years, if Culley and co are successful, we will be flirting with $8-$10.